Tag: Orforglipron

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Orforglipron

3 Stocks to Focus on as Demand for Obesity Drugs Booms - 24/7 Wall St.

Added to Collection on: 2023-09-30 21:00:44

Tags for this article:

Peptide hormones
Glucagon-like peptide-1 receptor agonist
Anti-obesity medication
Semaglutide
Retatrutide
Tirzepatide
Novo Nordisk
Obesity
Orforglipron
United States

Click the tags to see associated articles and topics

View Article Details
Pfizer selects once-daily GLP-1 for its obesity push - Pharmaphorum

Added to Collection on: 2024-07-12 20:13:39

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Semaglutide
GLP-1 receptor agonist
Amycretin
Anti-obesity medication
Tirzepatide
Glucagon-like peptide-1
Novo Nordisk
Orforglipron
Danuglipron
Ro
Eli Lilly
Pfizer
GLP-1

Click the tags to see associated articles and topics

View Article Details
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study - Yahoo Finance

Added to Collection on: 2024-07-12 19:27:44

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Fluoroarenes
Research and development in the United States
GLP-1 receptor agonist
Semaglutide
Anti-obesity medication
Glucagon-like peptide-1
Danuglipron
MariTide
Orforglipron
Pfizer
Pfizer Inc.
GLP-1

Click the tags to see associated articles and topics

View Article Details
Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues

Added to Collection on: 2024-07-12 16:42:13

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Semaglutide
GLP-1 receptor agonist
Cagrilintide/semaglutide
Anti-obesity medication
Retatrutide
Tirzepatide
Glucagon-like peptide-1
Orforglipron
Eli Lilly and Company
Novo Nordisk
Glucagon-Like Peptide 1

Click the tags to see associated articles and topics

View Article Details
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be ...

Added to Collection on: 2024-07-18 21:49:25

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Fluoroarenes
GLP-1 receptor agonist
Orforglipron
Glucagon-like peptide-1
Semaglutide
Pharmaceutical industry in China
Danuglipron
Anti-obesity medication
Novo Nordisk
Roche

Click the tags to see associated articles and topics

View Article Details
Analysts Weigh in on Eli Lilly Stock Following Roche's Weight Loss Drug Results - Tipranks

Added to Collection on: 2024-07-18 18:00:55

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Anti-obesity medication
Orforglipron
Semaglutide
Retatrutide
LLY
CT-388
Mazdutide
Tirzepatide
Glucagon-like peptide-1
Eli Lilly

Click the tags to see associated articles and topics

View Article Details